Healthy men test new version of arthritis drug
NCT ID NCT06262477
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called BIIB800 against an approved drug, Actemra, in 300 healthy men. The goal was to see if the two drugs behave similarly in the body and are equally safe. Participants received a single injection and were monitored for side effects and drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit Inc.
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Leeds, West Yorkshire, LS2 9LH, United Kingdom